EUVIMEDEUVIMED entdecken
Open Access

Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1

José Victor Zambrana iD, Chloe M Hasund iD, Rosemary A Aogo iD, Sandra Bos iD, Sonia Arguello iD, Karla Gonzalez iD, Damaris Collado iD, Tatiana Miranda iD, Guillermina Kuan iD, Aubree Gordon iD, Angel Balmaseda, Leah C Katzelnick iD und 1 weitere

Science Translational Medicine · 29.05.2024 · 16 (749)

DOI: 10.1126/scitranslmed.adn2199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 29.05.2024. Verfasst von José Victor Zambrana und 12 weiteren Autor:innen. Beteiligte Einrichtung: Sustainable Sciences Institute, Managua 14006, Nicaragua. Hauptthemen laut MEDLINE: Zika Virus, Dengue, Dengue Virus, Zika Virus Infection. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection with any of the four dengue virus serotypes (DENV1–4) can protect against or enhance subsequent dengue depending on preexisting antibodies and infecting serotype. Additionally, primary infection with the related flavivirus Zika virus (ZIKV) is associated with increased risk of DENV2 disease. Here, we measured how prior DENV and ZIKV immunity influenced risk of disease caused by DENV1–4 in a pediatric Nicaraguan cohort. Of 3412 participants in 2022, 10.6% experienced dengue cases caused by DENV1 ( n = 139), DENV4 ( n = 133), DENV3 ( n = 54), DENV2 ( n = 9), or an undetermined serotype ( n = 39). Longitudinal clinical and serological data were used to define infection histories, and generalized linear and additive models adjusted for age, sex, time since last infection, and year, and repeat measurements were used to predict disease risk. Compared with flavivirus-naïve participants, primary ZIKV infection was associated with increased risk of disease caused by DENV4 (relative risk = 2.62, 95% confidence interval: 1.48 to 4.63) and DENV3 (2.90, 1.34 to 6.27), but not DENV1 infection. Primary DENV infection or DENV followed by ZIKV infection was also associated with increased risk of DENV4 disease. We reanalyzed 19 years of cohort data and demonstrated that prior flavivirus immunity and antibody titer had distinct associations with disease risk depending on incoming serotype. We thus find that prior ZIKV infection, like prior DENV infection, is associated with increased risk of disease with certain DENV serotypes. Cross-reactivity among flaviviruses should be considered when assessing vaccine safety and efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika VirusDengueDengue VirusZika Virus InfectionSerogroupHumansChildFemaleMaleNicaraguaChild, PreschoolRisk FactorsAdolescentAntibodies, ViralCohort Studies

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Sustainable Sciences Institute, Managua 14006, Nicaragua.
  • Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
  • Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-3203, USA.
  • Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministerio de Salud, Managua 14062, Nicaragua.
  • Centro de Salud Sócrates Flores Vivas, Ministerio de Salud, Managua 12037, Nicaragua.

ORCID-Profile: José Victor Zambrana, Chloe M Hasund, Rosemary A Aogo, Sandra Bos, Sonia Arguello, Karla Gonzalez, Damaris Collado, Tatiana Miranda, Guillermina Kuan, Aubree Gordon, Leah C Katzelnick, Eva Harris

Förderung

  • NIAID NIH HHS

Zitieren

APA

Zambrana, J. V., Hasund, C. M., Aogo, R. A., Bos, S., Arguello, S., Gonzalez, K., Collado, D., Miranda, T., Kuan, G., Gordon, A., Balmaseda, A., Katzelnick, L. C., & Harris, E. (2024). Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1. Science Translational Medicine, 16(749). https://doi.org/10.1126/scitranslmed.adn2199

Vancouver

Zambrana JV, Hasund CM, Aogo RA, Bos S, Arguello S, Gonzalez K, et al. Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1. Science Translational Medicine. 2024;16(749). doi:10.1126/scitranslmed.adn2199

BibTeX
@article{Zambrana2024,
  author = {Zambrana, José Victor and Hasund, Chloe M and Aogo, Rosemary A and Bos, Sandra and Arguello, Sonia and Gonzalez, Karla and Collado, Damaris and Miranda, Tatiana and Kuan, Guillermina and Gordon, Aubree and Balmaseda, Angel and Katzelnick, Leah C and Harris, Eva},
  title = {Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1},
  journal = {Science Translational Medicine},
  year = {2024},
  volume = {16},
  number = {749},
  doi = {10.1126/scitranslmed.adn2199}
}
Kostenlos starten →